For: | Chau GY. Resection of hepatitis B virus-related hepatocellular carcinoma: Evolving strategies and emerging therapies to improve outcome. World J Gastroenterol 2014; 20(35): 12473-12484 [PMID: 25253947 DOI: 10.3748/wjg.v20.i35.12473] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i35/12473.htm |
Number | Citing Articles |
1 |
Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Yun-Hsuan Lee, Yi-Hsiang Huang, Chien-Wei Su, Fa-Yauh Lee, Han-Chieh Lin, Teh-Ia Huo. Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients. European Journal of Cancer 2016; 63: 25 doi: 10.1016/j.ejca.2016.04.023
|
2 |
Hon-Fan Lai, Ivy Yenwen Chau, Hao-Jan Lei, Shu-Cheng Chou, Cheng-Yuan Hsia, Yi-Chu Kao, Gar-Yang Chau, Leonidas G Koniaris. Postoperative fever after liver resection: Incidence, risk factors, and characteristics associated with febrile infectious complication. PLOS ONE 2022; 17(1): e0262113 doi: 10.1371/journal.pone.0262113
|
3 |
Y J Chang, K P Chung, Y J Chang, L J Chen. Long-term survival of patients undergoing liver resection for very large hepatocellular carcinomas. Journal of British Surgery 2016; 103(11): 1513 doi: 10.1002/bjs.10196
|
4 |
De-Fei Hong, Ying-Bin Liu, Shu-You Peng, Jin-Zhong Pang, Zhi-Fei Wang, Jian Cheng, Guo-Liang Shen, Yuan-Biao Zhang. Management of hepatocellular carcinoma rupture in the caudate lobe. World Journal of Gastroenterology 2015; 21(26): 8163-8169 doi: 10.3748/wjg.v21.i26.8163
|
5 |
Yiqi Yu, Jingwen Ai, Wenhong Zhang. Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2017; 11(10): 925 doi: 10.1080/17474124.2017.1343665
|
6 |
Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Yun-Hsuan Lee, Chien-Wei Su, Yi-Hsiang Huang, Fa-Yauh Lee, Han-Chieh Lin, Teh-Ia Huo. Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems. Journal of Hepatology 2016; 64(3): 601 doi: 10.1016/j.jhep.2015.10.029
|
7 |
Qiang Fang, Qing-Song Xie, Jiang-Ming Chen, Shen-Liang Shan, Kun Xie, Xiao-Ping Geng, Fu-Bao Liu. Long-term outcomes after hepatectomy of huge hepatocellular carcinoma: A single-center experience in China. Hepatobiliary & Pancreatic Diseases International 2019; 18(6): 532 doi: 10.1016/j.hbpd.2019.09.001
|
8 |
Z. M. Younossi, M. Stepanova, S. Saab, A. Ahmed, B. Lam, M. Srishord, C. Venkatesan, H. Wai, L. Henry. The impact of viral hepatitis‐related hepatocellular carcinoma to post‐transplant outcomes. Journal of Viral Hepatitis 2016; 23(1): 53 doi: 10.1111/jvh.12449
|
9 |
Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Yun-Hsuan Lee, Yi-Hsiang Huang, Yi-You Chiou, Han-Chieh Lin, Teh-Ia Huo. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2 cm in a Propensity Score Model. Annals of Surgery 2016; 263(3): 538 doi: 10.1097/SLA.0000000000001178
|
10 |
Po‐Hong Liu, Chia‐Yang Hsu, Cheng‐Yuan Hsia, Yun‐Hsuan Lee, Yi‐You Chiou, Yi‐Hsiang Huang, Fa‐Yauh Lee, Han‐Chieh Lin, Ming‐Chih Hou, Teh‐Ia Huo. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era. Journal of Gastroenterology and Hepatology 2017; 32(4): 879 doi: 10.1111/jgh.13608
|
11 |
Yueming Zhang, Jing Lv, Pingguo Liu, Xingyang Zhao, Kang Chen, Qiaolin Li, Liming Nie, Chihua Fang. Contrast-Enhanced Multispectral Photoacoustic Imaging for Irregular Hepatectomy Navigation: A Pilot Study. ACS Biomaterials Science & Engineering 2020; 6(10): 5874 doi: 10.1021/acsbiomaterials.0c00921
|
12 |
Po-Hong Liu, Chia-Yang Hsu, Yun-Hsuan Lee, Chien-Wei Su, Cheng-Yuan Hsia, Yi-Hsiang Huang, Yi-You Chiou, Han-Chieh Lin, Teh-Ia Huo. Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma. Medicine 2015; 94(41): e1772 doi: 10.1097/MD.0000000000001772
|
13 |
Chiara Rocha, Joseph Di Norcia, Parissa Tabrizian, Chiara Di Renzo, Salvatore Amodeo, Yuki Bekki, Mohammed Z. Akhtar, Marcelo E. Facciuto, Thomas D. Schiano, Sander Florman, Myron Schwartz. Improved outcomes of liver resection for hepatitis C-related hepatocellular carcinoma after the introduction of direct-acting antiviral therapy. HPB 2024; 26(8): 1007 doi: 10.1016/j.hpb.2024.04.014
|
14 |
Guanlin Zhou, Yijun Zeng, Yingmin Luo, Sheng Guo, Longyuan Bao, Qiong Zhang. Urine miR-93-5p is a promising biomarker for early detection of HBV-related hepatocellular carcinoma. European Journal of Surgical Oncology 2022; 48(1): 95 doi: 10.1016/j.ejso.2021.06.015
|
15 |
Heng Lu, Xin Zhao, Wen-Jiang Lu, Jie Yang, Zhao-Hua Zhou, Ze-Hua Lei, Qing-Yun Xie. Erector Spinae Plane Block for Pain Management in Hepatocellular Carcinoma Patients Undergoing Laparoscopic Left Hemihepatectomy: A Retrospective Propensity Score-matched Study. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2024; doi: 10.1097/SLE.0000000000001344
|
16 |
Sheng-Yu Wang, Ivy Yenwen Chau, Cheng-Yuan Hsia, Hao-Jan Lei, Shu-Cheng Chou, Yi-Chu Kao, Gar-Yang Chau. Resection of hepatocellular carcinoma in patients with portal hypertension: long-term results based on direct intraoperative measurement of portal venous pressure. International Journal of Surgery: Global Health 2020; 3(6): e34 doi: 10.1097/GH9.0000000000000034
|
17 |
Yu-Wen Su, Po-Hong Liu, Chia-Yang Hsu, Yun-Hsuan Lee, Cheng-Yuan Hsia, Shu-Yein Ho, Ming-Chih Hou, Harn-Shen Chen, Teh-Ia Huo, Sheng-Nan Lu. Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective. PLOS ONE 2017; 12(3): e0174333 doi: 10.1371/journal.pone.0174333
|